Showing 1 - 6 results of 6 for search 'Christopher Hackenbruch', query time: 0.03s
Refine Results
-
1
-
2
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal can... by Susanne Jung, Susanne Jung, Susanne Jung, Richard F. Schlenk, Richard F. Schlenk, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Sandra S.L. Roldan Pinzon, Michael Bitzer, Martin Pflügler, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Gundram Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih
Published 2024-02-01
Article -
3
-
4
iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens by Alexander Englisch, Alexander Englisch, Alexander Englisch, Clara Hayn, Clara Hayn, Susanne Jung, Susanne Jung, Susanne Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Marcel Wacker, Marcel Wacker, Monika Denk, Lisa Zieschang, Christine Kammer, Peter Martus, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz
Published 2024-08-01
Article -
5
AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell an... by Susanne Jung, Susanne Jung, Susanne Jung, Annika Nelde, Annika Nelde, Yacine Maringer, Yacine Maringer, Monika Denk, Monika Denk, Monika Denk, Lisa Zieschang, Lisa Zieschang, Lisa Zieschang, Christine Kammer, Christine Kammer, Melek Özbek, Melek Özbek, Melek Özbek, Peter Martus, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Alexander Englisch, Alexander Englisch, Alexander Englisch, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz
Published 2024-10-01
Article -
6
FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellu... by Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Jens Bauer, Jens Bauer, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Monika Denk, Monika Denk, Lisa Zieschang, Lisa Zieschang, Christine Kammer, Christine Kammer, Birgit Federmann, Birgit Federmann, Birgit Federmann, Susanne Jung, Susanne Jung, Susanne Jung, Peter Martus, Nisar P. Malek, Nisar P. Malek, Nisar P. Malek, Nisar P. Malek, Nisar P. Malek, Konstantin Nikolaou, Konstantin Nikolaou, Konstantin Nikolaou, Helmut R. Salih, Helmut R. Salih, Michael Bitzer, Michael Bitzer, Michael Bitzer, Michael Bitzer, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz
Published 2024-03-01
Article